Showing results (2801-2810 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|October 28, 2026
Outcomes of Chemoimmunotherapy in Metastatic Pancreatic Neuroendocrine Carcinoma: A Single-Center Clinicopathologic StudyDrew Moss, Catherine A O'Connor, Marc Hilmi, et al.
The Oncologist|November 6, 2026
Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinationsGiulia Claire Giudice, Hassan Mohammed Abushukair, Giulia Mazzaschi, et al.
The Oncologist|September 20, 2022
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety AnalysesNiven Mehra, Karim Fizazi, Johann S de Bono, et al.
The Oncologist|October 14, 2022
A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western KenyaSinéad Isaacson, Konyin Adewumi, Jennifer S Smith, et al.
The Oncologist|October 18, 2014
MicroRNA expression profiles in the management of papillary thyroid cancerJames C Lee, Justin S Gundara, Anthony Glover, et al.
The Oncologist|June 23, 2016
Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis MarkersMartha W den Hollander, Nico-Derk L Westerink, Sjoukje Lubberts, et al.
The Oncologist|June 19, 2016
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic OpportunitiesMallika Dhawan, Charles J Ryan, Alan Ashworth
The Oncologist|June 19, 2016
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur WomenGulixian Tuerxun, Awaguli Yukesaier, Ling Lu, et al.
The Oncologist|May 7, 2016
A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer PatientAndrew M Whitman, Kathlene A DeGregory, Amy L Morris, et al.
The Oncologist|May 7, 2016
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical TrialsJames H Suh, Adrienne Johnson, Lee Albacker, et al.
Pageof 571